The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients;Ausencia de relación entre los genotipos de apolipoproteína E y la gravedad de la esclerosis múltiple en pacientes mexicanos

Revista de Neurologia

Volumn 50, Issue 1, 2010, Pages 19-22

  Corona, Teresa ^a   Guerrero Camacho, Jorge L ^a   Alonso Vilatela, M Elisa ^a   Flores Rivera, José De Jesús ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Apolipoprotein E; Genotype; Mexico; Multiple sclerosis; Progression

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; GENOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; ONSET AGE; PHYSICAL DISABILITY; RELAPSE; SCORING SYSTEM;

EID: 76749086985     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5001.2008129     Document Type: Article

References (20)

1. Kantarci O, Weinshenker B. Natural history of MS. Neurol Clin 2005; 23: 17.
2. Chapman J, Sylantiev C, Nisipeanu P, Korczyn AY. Preliminary observations on ApoE ε4 allele and progression of disability in multiple sclerosis. Arch Neurol 1999; 56: 1484-7.
3. Saunders AM, Strittmatter WJ, Schemechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein allele ε4 with late onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72.
4. Mahley R. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-30.
5. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994; 17: 525-30.
6. Chapman J, Vinokurou S, Achiron A, Karussis DM, Mitosek-Szewczyk K, Birnbaum M, et al. ApoE genotype is a major predictor of long-term, progression of disability in MS. Neurology 2001; 56: 312-6.
7. Evangelou N, Jackson M, Beeson D, Palace J. Association of the ApoE epsilon 4 allele with activity in multiple sclerosis. J Neurol Neurosurg Pschiatry; 1999; 67: 203-5.
8. Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H, et al. Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis Neurology 2001; 57: 853-7.
9. Schmidt S, Barcellos F, De Sambre K, Rimmler JB, Lincoln RR, Bucher P, et al, for the Multiple Sclerosis Genetic Group. Association of polymorphism in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am J Hum Genet 2002; 70: 708-17.
10. Hogh P, Oturai A, Schreiber K, Blinkenberg M, Jorgensen OS, Ryder L, et al. Apolipoprotein E and multiple sclerosis impact of the epsilon-4-allele on susceptibility, clinical type and progression rate. Mult Scler 2000; 4: 226-30.
11. Masterman T, Zhang Z, Hellgren D, Salter H, Anvret M, Lilis L, et al. ApoE genotypes and disease severity in multiple sclerosis. Mult Scler 2002; 8: 98-103.
12. Kantarci OH, Henbrink DD, Achenbach SJ, Pittock SJ, Altintas A, Shaefer-Klein JL, et al. Association of ApoE polymorphism with disease severity in MS is limited to women. Neurology 2004; 62: 811-4.
13. Schreiber K, Otura AB, Ryder LP, Madsen H O, Jorgensen OS, Svejgaard A, et al. Disease severity in Danish multiple sclerosis patients evaluated by MR1 and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E). Mult Scler 2002; 4: 295-8.
14. Weathebly SJ, Mann CL, Davies MB, Carthy D, Fryer CD, Boggild AA, et al. Polymorphisms of apolipoprotein E, outcome and susceptibility in multiple sclerosis. Mult Scler 2000; 6: 32-6.
15. Fazekas F, Enzinger CH, Ropele S, Schmidt H, Schmidt R, Strasser-Fuchs S. The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis. J Neurol Sci 2006; 245: 35-9.
16. Guerrero AL, Bueno V, Hernández MT, Martín-Serrodilla JM, Carrasco E, Cuadrado I. El polimorfismo de la apolipoproteína E como marcador pronóstico de la esclerosis múltiple. Neurologia 2003; 18: 146-8.
17. Burwick RM, Ramsay PP, Haines JL, Hauses SL, Oksenberg JR, Pericak-Vance MA, et al. ApoE epsilon variation in multiple sclerosis susceptibility and disease severity. Neurology 2006; 66: 1373-83.
18. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha1. J Lipid Res 1990; 31: 545-8.
19. Ramagopalan SV, DeLuca GC, Morrison KM, Herrera MB, Dyment DA, Orton S, et al. No effect of ApoE and PVRL2 on the clinical outcome of multiple sclerosis. J Neuroinmunol 2007; 186: 156-60.
20. Corona T, Roman GC. Multiple sclerosis in Latin America. Neuroepidemiology 2006; 26: 1-3.